際際滷

際際滷Share a Scribd company logo
RECEPTOR PHARMACOLOGY
GENERAL ASPECTS OF RECEPTOR PHARMACOLOGY
STRUCTURAL AND FUNCTIONAL ASPECTS OF RECEPTORS
BY
Mahender.K
M.Pharm 1st yr 2nd sem.
Srikrupa institute of pharmaceutical sciences,
Velkatta,kondapak,medak.
Andhra pradesh.
Under the guidance of
Dr. T.Shivaraj gouda M.pharm.,PhD
H.O.D. (Pharmacology)
RECEPTOR
 A receptor is a molecule most often found on the
surface of a cell, which receives chemical signals
originating externally from the cell.
 Through binding to a receptor, these signals direct
a cell to do somethingfor example to divide or
die, or to allow certain molecules to enter or exit.
Mine ap
Targets for drug action
 Receptors are protein molecules, embedded in either the
plasma membrane (cell surface receptors) or the
cytoplasm or nucleus (nuclear receptors) of a cell, to
which one or more specific kinds of signaling molecules
may attach.
 A molecule which binds (attaches) to a receptor is called
a ligand, and may be a peptide (short protein) or other
small molecule, such as a neurotransmitter, a hormone, a
pharmaceutical drug, or a toxin.
 Numerous receptor types are found within a typical cell
and each type is linked to a specific biochemical
pathway.
 Furthermore each type of receptor recognizes and binds
only certain ligand shapes (in analogy to a lock and key
where the lock represents the receptor and the key, its
ligand).
 Hence the selective binding of specific a ligand to its
receptor activates or inhibits a specific biochemical
pathway.
CLASSIFICATION:
 By Modality and adequate stimulus
 Mechanical input - mechanoreceptors (touch, pressure, stretching, movements)
 Electromagnetic - photoreceptors (light)
 Chemoreceptors (taste, smell, oxygen level)
 Thermoreceptors (cold, warmth)
 Electrical  electroreceptors
 By Overall function
 Exteroreceptors - cutaneously located, responsible for providing information from the
immediate environment
 Telereceptors - sense events that originate at some distance from the body (such as in
eyes, ears, olfactory receptors)
 Interoceptors - respond to stimuli originating in the visceral organs
 Proprioceptors - convey information about the relative position of the body parts
(located in skeletal muscles, tendons, joints, vestibular apparatus)
 Clinical classification
 This classification is derived from the pathway by which the primary afferent axons
enter the CNS.
 Special sensory receptors - served by cranial nerves
 Cutaneous receptors - innervated by superficial branches of spinal and cranial nerves
 Deep receptors - located in muscles, tendons and joints, served by deeper branches of
spinal and cranial nerves
 Visceral receptors. - served by afferent axons associated with the autonomic nervous
system
Mine ap
Mine ap
LIGAND-GATED ION CHANNELS
 Ligand-gated ion channels (LGICs) are one type of ionotropic
receptor or channel-linked receptor. They are a group of
transmembrane ion channels that are opened or closed in response
to the binding of a chemical messenger (i.e., a ligand),such as a
neurotransmitter.
 The binding site of endogenous ligands on LGICs protein complexes
are normally located on a different portion of the protein (an allosteric
binding site) compared to where the ion conduction pore is located.
 The direct link between ligand binding and opening or closing of the
ion channel, which is characteristic of ligand-gated ion channels, is
contrasted with the indirect function of metabotropic receptors, which
use second messengers. LGICs are also different from voltage-gated
ion channels (which open and close depending on membrane
potential), and stretch-activated ion channels (which open and close
depending on mechanical deformation of the cell membrane)
STRUCTURE:
Mine ap
 The five receptor sub units (2留,硫,粒,隆) form a cluster
surrounding a central transmembrane pore, the
lining is formed by M2 hellical segment of each
subunit.
 These contains a preponderance of negatively
charged amino acids , which makes the pore cation
selective.
 There are two Ach binding sites in the extracellular
portion of the receptor, at the interface between the
alpha and the adjoining sub units.
 When two Ach binds the 留 helices swing out of the
way thus opening the channel pore.
G PROTEIN-COUPLED RECEPTOR
 It consists of a single polypeptide chain of up to
1100 residues.
 Their characteristic structure consists of 7 trans
membrane alpha helicessimilar to those of ion
channels, with an extracellular N terminal domain of
varying length and intracellular C terminal domain.
Mine ap
FUNCTION
 It consists of three sub units which are anchored to the
membrane through attached lipase residues.
 Coupling of the alpha sub unit to an agonist occupied
receptor causes the bound GDP to exchange with
intracellular GTP the alpha GTP complex then
dissociates from the receptor and from the beta gamma
complex and interacts with a target protein(target 1),
which may also activate a target protein(target 2) .
 The GTPase activity of the alpha sub unit is increased
when the target protein is bound,leading to hydrolysis of
the bound GTP to GDP where upon the alpha sub unit
reunites with beta gamma.
Mine ap
KINASE LINKED RECPTORS
 These mediate the action of wide variety of protein
mediators including growth factors, cytokines and
hormones such as insulin and leptin whose effects
are exercted mainly at the level of gene
transcription.
 These are large proteins consisting of single chain
up to 1000 residues with a single membrane
spannig helical region assosiated with a large
extracellular ligand binding domain and intracellular
kinase domain.
Mine ap
 Receptors of various growth factors incorporate tyrosine
kinase in their intracellular domain.
 Cytokine receptors have an intracellular domain that
binds and activates cytosolic kinase when the receptor is
occupied.
 Signal transduction generally involves dimerisation of
receptors, followed by autophosporylation of tyrosine
residues. The posphotyrosine residues acts as acceptors
for SH2domains of intra cellular proteins,there by
allowing control of many cell functions,
Mine ap
NUCLEAR RECEPTORS
 Two main categories
o those that are present in the cytoplasm form homodimers
in the presence of their partner, and migrate to the
nucleus. Their ligands are endocrine in nature
(eg:steroidal hormones).
o those that are generally present in the nucleus and
form heterodimers with the retenoid X receptor. Their
ligands are usually lipids.(eg:fatty acids)
o third sub group tranduce mainly endocrine signals but
function as heterodimers with retenoid X receptor
.(eg:thyroid hormone)
 The receptor family is responsible for the pharmacology
of appx.10% and pharmacokinetics of 60% of all
prescribed drugs.
Mine ap
THANK YOU
Ad

Recommended

Introduction to autonomic pharmacology
Introduction to autonomic pharmacology
UsmanKhalid135
Non adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmitters
Rahulvaish13
Dr tarek NSAIDs
Dr tarek NSAIDs
al azhar universty
Alternatives to animal experiments
Alternatives to animal experiments
Dr. Mohit Kulmi
Local Anesthetics
Local Anesthetics
Sujit Karpe
Pain pathway
Pain pathway
PGINeurosurgery
Immunotherapeutics and Humanisation of antibodies
Immunotherapeutics and Humanisation of antibodies
Sanju Kaladharan
Neurohumoral transmission in ans final fully1cl f
Neurohumoral transmission in ans final fully1cl f
rahulsharma3589
Pharmacogenomics
Pharmacogenomics
ANAND SAGAR TIWARI
(Anti-fungal Drugs) pharmacology
(Anti-fungal Drugs) pharmacology
AbhinayJha3
RECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASE
sharad patange
screening model for parkinsons disease
screening model for parkinsons disease
Kundlik Rathod
Glutamate
Glutamate
ayanarkumar19
Anxiolytic screening models_utkarsh
Anxiolytic screening models_utkarsh
Utkarsh Alok
Tyrosine kinase receptors & Nuclear receptors
Tyrosine kinase receptors & Nuclear receptors
Aaqib Naseer
Local anesthetics
Local anesthetics
Subhash Yende
Antisense oligonucleotide therapy
Antisense oligonucleotide therapy
pharmacologyseminars
Neurohumoral Transmission of Acetylcholine.pptx
Neurohumoral Transmission of Acetylcholine.pptx
ShraddhaRaut43
Epilepsy recent advances and existing pharmacotherapy
Epilepsy recent advances and existing pharmacotherapy
Dr. Siddhartha Dutta
Receptors as Drug Targets
Receptors as Drug Targets
Htet Wai Moe
INHALATIONAL TOXICITY STUDIES.M pharmacy
INHALATIONAL TOXICITY STUDIES.M pharmacy
AartiPal23
Neurosteroids and neuropeptides
Neurosteroids and neuropeptides
Jonaid Ali
Screening methods for analgesics
Screening methods for analgesics
Dr. Amit Sharma
Screening methods for analgesics
Screening methods for analgesics
Amy Mehaboob
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Ansari Aashif Raza Mohd Imtiyaz
ANS
ANS
Ashfaqur Rahman
Genetics variations in gpcr
Genetics variations in gpcr
Deepak Kumar
Antisense oligonucleotide therapy
Antisense oligonucleotide therapy
ROHIT
3. molecular mech of drug action presentn
3. molecular mech of drug action presentn
suniu
Biological drug targets.pptx
Biological drug targets.pptx
PurushothamKN1

More Related Content

What's hot (20)

Pharmacogenomics
Pharmacogenomics
ANAND SAGAR TIWARI
(Anti-fungal Drugs) pharmacology
(Anti-fungal Drugs) pharmacology
AbhinayJha3
RECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASE
sharad patange
screening model for parkinsons disease
screening model for parkinsons disease
Kundlik Rathod
Glutamate
Glutamate
ayanarkumar19
Anxiolytic screening models_utkarsh
Anxiolytic screening models_utkarsh
Utkarsh Alok
Tyrosine kinase receptors & Nuclear receptors
Tyrosine kinase receptors & Nuclear receptors
Aaqib Naseer
Local anesthetics
Local anesthetics
Subhash Yende
Antisense oligonucleotide therapy
Antisense oligonucleotide therapy
pharmacologyseminars
Neurohumoral Transmission of Acetylcholine.pptx
Neurohumoral Transmission of Acetylcholine.pptx
ShraddhaRaut43
Epilepsy recent advances and existing pharmacotherapy
Epilepsy recent advances and existing pharmacotherapy
Dr. Siddhartha Dutta
Receptors as Drug Targets
Receptors as Drug Targets
Htet Wai Moe
INHALATIONAL TOXICITY STUDIES.M pharmacy
INHALATIONAL TOXICITY STUDIES.M pharmacy
AartiPal23
Neurosteroids and neuropeptides
Neurosteroids and neuropeptides
Jonaid Ali
Screening methods for analgesics
Screening methods for analgesics
Dr. Amit Sharma
Screening methods for analgesics
Screening methods for analgesics
Amy Mehaboob
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Ansari Aashif Raza Mohd Imtiyaz
ANS
ANS
Ashfaqur Rahman
Genetics variations in gpcr
Genetics variations in gpcr
Deepak Kumar
Antisense oligonucleotide therapy
Antisense oligonucleotide therapy
ROHIT
(Anti-fungal Drugs) pharmacology
(Anti-fungal Drugs) pharmacology
AbhinayJha3
RECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASE
sharad patange
screening model for parkinsons disease
screening model for parkinsons disease
Kundlik Rathod
Anxiolytic screening models_utkarsh
Anxiolytic screening models_utkarsh
Utkarsh Alok
Tyrosine kinase receptors & Nuclear receptors
Tyrosine kinase receptors & Nuclear receptors
Aaqib Naseer
Local anesthetics
Local anesthetics
Subhash Yende
Antisense oligonucleotide therapy
Antisense oligonucleotide therapy
pharmacologyseminars
Neurohumoral Transmission of Acetylcholine.pptx
Neurohumoral Transmission of Acetylcholine.pptx
ShraddhaRaut43
Epilepsy recent advances and existing pharmacotherapy
Epilepsy recent advances and existing pharmacotherapy
Dr. Siddhartha Dutta
Receptors as Drug Targets
Receptors as Drug Targets
Htet Wai Moe
INHALATIONAL TOXICITY STUDIES.M pharmacy
INHALATIONAL TOXICITY STUDIES.M pharmacy
AartiPal23
Neurosteroids and neuropeptides
Neurosteroids and neuropeptides
Jonaid Ali
Screening methods for analgesics
Screening methods for analgesics
Dr. Amit Sharma
Screening methods for analgesics
Screening methods for analgesics
Amy Mehaboob
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Ansari Aashif Raza Mohd Imtiyaz
Genetics variations in gpcr
Genetics variations in gpcr
Deepak Kumar
Antisense oligonucleotide therapy
Antisense oligonucleotide therapy
ROHIT

Similar to Mine ap (20)

3. molecular mech of drug action presentn
3. molecular mech of drug action presentn
suniu
Biological drug targets.pptx
Biological drug targets.pptx
PurushothamKN1
Receptor basics
Receptor basics
FoziyaKhan
Receptors
Receptors
NITESH KUMAR
Receptors 1
Receptors 1
Sayeed Samrul
Receptors-1
Receptors-1
Samrul Islam
receptors.pptx and its types and mechanism
receptors.pptx and its types and mechanism
GuttiKrishnasriRolln
Receptors seminar.pptx
Receptors seminar.pptx
RashuRaju
Pharmacology Unit - 2.pptx
Pharmacology Unit - 2.pptx
Nikita Gupta
Unit 2 General Pharmacology (As per PCI syllabus)
Unit 2 General Pharmacology (As per PCI syllabus)
Mirza Anwar Baig
General physiology of receptor
General physiology of receptor
sunil rapolu
Role of receptors in drug design
Role of receptors in drug design
Roshni Ann
Receptors Types and details
Receptors Types and details
Shilpa Harak
The Mechanisms of Drug Actions in Pharmacology
The Mechanisms of Drug Actions in Pharmacology
sedataltugtr
Receptor
Receptor
Stanley Palma
Receptor pharmacology Uttam & Renoo
Receptor pharmacology Uttam & Renoo
uttam singh
Drug receptors in pharmacology
Drug receptors in pharmacology
Bindu Pulugurtha
Physiological receptors
Physiological receptors
Santosh Mogali
Receptor
Receptor
Jai Narain Vyas University Jodhpur Rajasthan India 342003
Receptor seminar by Dr.Mahi Yeruva
Receptor seminar by Dr.Mahi Yeruva
Mahi Yeruva
3. molecular mech of drug action presentn
3. molecular mech of drug action presentn
suniu
Biological drug targets.pptx
Biological drug targets.pptx
PurushothamKN1
Receptor basics
Receptor basics
FoziyaKhan
receptors.pptx and its types and mechanism
receptors.pptx and its types and mechanism
GuttiKrishnasriRolln
Receptors seminar.pptx
Receptors seminar.pptx
RashuRaju
Pharmacology Unit - 2.pptx
Pharmacology Unit - 2.pptx
Nikita Gupta
Unit 2 General Pharmacology (As per PCI syllabus)
Unit 2 General Pharmacology (As per PCI syllabus)
Mirza Anwar Baig
General physiology of receptor
General physiology of receptor
sunil rapolu
Role of receptors in drug design
Role of receptors in drug design
Roshni Ann
Receptors Types and details
Receptors Types and details
Shilpa Harak
The Mechanisms of Drug Actions in Pharmacology
The Mechanisms of Drug Actions in Pharmacology
sedataltugtr
Receptor pharmacology Uttam & Renoo
Receptor pharmacology Uttam & Renoo
uttam singh
Drug receptors in pharmacology
Drug receptors in pharmacology
Bindu Pulugurtha
Physiological receptors
Physiological receptors
Santosh Mogali
Receptor seminar by Dr.Mahi Yeruva
Receptor seminar by Dr.Mahi Yeruva
Mahi Yeruva
Ad

More from mahender Kotte (7)

My ppt.
My ppt.
mahender Kotte
My ppt
My ppt
mahender Kotte
Patch clamp technique
Patch clamp technique
mahender Kotte
Mahi ddmp
Mahi ddmp
mahender Kotte
Mine...
Mine...
mahender Kotte
molecular biology techniques
molecular biology techniques
mahender Kotte
IPR NDA and ANDA
IPR NDA and ANDA
mahender Kotte
Ad

Mine ap

  • 1. RECEPTOR PHARMACOLOGY GENERAL ASPECTS OF RECEPTOR PHARMACOLOGY STRUCTURAL AND FUNCTIONAL ASPECTS OF RECEPTORS BY Mahender.K M.Pharm 1st yr 2nd sem. Srikrupa institute of pharmaceutical sciences, Velkatta,kondapak,medak. Andhra pradesh. Under the guidance of Dr. T.Shivaraj gouda M.pharm.,PhD H.O.D. (Pharmacology)
  • 2. RECEPTOR A receptor is a molecule most often found on the surface of a cell, which receives chemical signals originating externally from the cell. Through binding to a receptor, these signals direct a cell to do somethingfor example to divide or die, or to allow certain molecules to enter or exit.
  • 5. Receptors are protein molecules, embedded in either the plasma membrane (cell surface receptors) or the cytoplasm or nucleus (nuclear receptors) of a cell, to which one or more specific kinds of signaling molecules may attach. A molecule which binds (attaches) to a receptor is called a ligand, and may be a peptide (short protein) or other small molecule, such as a neurotransmitter, a hormone, a pharmaceutical drug, or a toxin.
  • 6. Numerous receptor types are found within a typical cell and each type is linked to a specific biochemical pathway. Furthermore each type of receptor recognizes and binds only certain ligand shapes (in analogy to a lock and key where the lock represents the receptor and the key, its ligand). Hence the selective binding of specific a ligand to its receptor activates or inhibits a specific biochemical pathway.
  • 7. CLASSIFICATION: By Modality and adequate stimulus Mechanical input - mechanoreceptors (touch, pressure, stretching, movements) Electromagnetic - photoreceptors (light) Chemoreceptors (taste, smell, oxygen level) Thermoreceptors (cold, warmth) Electrical electroreceptors By Overall function Exteroreceptors - cutaneously located, responsible for providing information from the immediate environment Telereceptors - sense events that originate at some distance from the body (such as in eyes, ears, olfactory receptors) Interoceptors - respond to stimuli originating in the visceral organs Proprioceptors - convey information about the relative position of the body parts (located in skeletal muscles, tendons, joints, vestibular apparatus) Clinical classification This classification is derived from the pathway by which the primary afferent axons enter the CNS. Special sensory receptors - served by cranial nerves Cutaneous receptors - innervated by superficial branches of spinal and cranial nerves Deep receptors - located in muscles, tendons and joints, served by deeper branches of spinal and cranial nerves Visceral receptors. - served by afferent axons associated with the autonomic nervous system
  • 10. LIGAND-GATED ION CHANNELS Ligand-gated ion channels (LGICs) are one type of ionotropic receptor or channel-linked receptor. They are a group of transmembrane ion channels that are opened or closed in response to the binding of a chemical messenger (i.e., a ligand),such as a neurotransmitter. The binding site of endogenous ligands on LGICs protein complexes are normally located on a different portion of the protein (an allosteric binding site) compared to where the ion conduction pore is located. The direct link between ligand binding and opening or closing of the ion channel, which is characteristic of ligand-gated ion channels, is contrasted with the indirect function of metabotropic receptors, which use second messengers. LGICs are also different from voltage-gated ion channels (which open and close depending on membrane potential), and stretch-activated ion channels (which open and close depending on mechanical deformation of the cell membrane)
  • 13. The five receptor sub units (2留,硫,粒,隆) form a cluster surrounding a central transmembrane pore, the lining is formed by M2 hellical segment of each subunit. These contains a preponderance of negatively charged amino acids , which makes the pore cation selective. There are two Ach binding sites in the extracellular portion of the receptor, at the interface between the alpha and the adjoining sub units. When two Ach binds the 留 helices swing out of the way thus opening the channel pore.
  • 14. G PROTEIN-COUPLED RECEPTOR It consists of a single polypeptide chain of up to 1100 residues. Their characteristic structure consists of 7 trans membrane alpha helicessimilar to those of ion channels, with an extracellular N terminal domain of varying length and intracellular C terminal domain.
  • 17. It consists of three sub units which are anchored to the membrane through attached lipase residues. Coupling of the alpha sub unit to an agonist occupied receptor causes the bound GDP to exchange with intracellular GTP the alpha GTP complex then dissociates from the receptor and from the beta gamma complex and interacts with a target protein(target 1), which may also activate a target protein(target 2) . The GTPase activity of the alpha sub unit is increased when the target protein is bound,leading to hydrolysis of the bound GTP to GDP where upon the alpha sub unit reunites with beta gamma.
  • 19. KINASE LINKED RECPTORS These mediate the action of wide variety of protein mediators including growth factors, cytokines and hormones such as insulin and leptin whose effects are exercted mainly at the level of gene transcription. These are large proteins consisting of single chain up to 1000 residues with a single membrane spannig helical region assosiated with a large extracellular ligand binding domain and intracellular kinase domain.
  • 21. Receptors of various growth factors incorporate tyrosine kinase in their intracellular domain. Cytokine receptors have an intracellular domain that binds and activates cytosolic kinase when the receptor is occupied. Signal transduction generally involves dimerisation of receptors, followed by autophosporylation of tyrosine residues. The posphotyrosine residues acts as acceptors for SH2domains of intra cellular proteins,there by allowing control of many cell functions,
  • 23. NUCLEAR RECEPTORS Two main categories o those that are present in the cytoplasm form homodimers in the presence of their partner, and migrate to the nucleus. Their ligands are endocrine in nature (eg:steroidal hormones). o those that are generally present in the nucleus and form heterodimers with the retenoid X receptor. Their ligands are usually lipids.(eg:fatty acids) o third sub group tranduce mainly endocrine signals but function as heterodimers with retenoid X receptor .(eg:thyroid hormone) The receptor family is responsible for the pharmacology of appx.10% and pharmacokinetics of 60% of all prescribed drugs.